View this message in your browser
 
18 October 2010

Take full advantage of Biofit´s Partnering Opportunities and register today
 
Before Biofit
   

Conducting business meetings at Partnering Conferences has become an intrinsic part of the business development activities of biotech and pharma executives and now academia representatives.

Biofit 2010 is glad to count for its first edition so many prestigious participants. With such profiles, there is no doubt it will give birth to some of the tomorrow’s most innovative collaborative projects.

Do not miss out on this excellent opportunity to meet future partners!
Join us in Lille

 

Biofit program







 



Biofit Partnering 2010 key figures

 228  Companies and 300 Delegates from more than 23 countries available on line

  More than 219 Licensing opportunities posted

  More than 1000 meetings requests sent on the platform (100% increased in one week)

 
40 one-to-one meetings slots available for each participant in two days

View the preliminary list
of participating companies


Biofit 2010 Highlights

  Academia (TTOs and researchers in numerous aera) presence: 37%

  Biotechnology: 34%

  Pharma / Medical Technology: 15%

  Investor: 3%

  Professional Services and Consulting / Supplier & Engineering: 11%

  More than 30 renowned speakers giving their opinion on Open Innovation issues: G. Steven Burrill, Ashley Stevens, Ludo F. Lauwers, Neil Weir, etc.

View the conference program


Direct links

  Partnering
  Conferences
  Presenting companies
  Presenting technologies
  Exhibition




Major sponsor
Silver sponsor
Silver sponsor
Silver sponsor
Contributing sponsors
Contributing sponsors
Conference program sponsor
Plenary session

We are very proud and honored to announce the program of the Plenary Assembly which will officially launch the new international event Biofit.

Organized on Tuesday 26th October 2010 from 11:00am to 12:30pm, the Plenary session will offer you the opportunity to attend to a cutting-edge discussion between four prestigious speakers:

M. G. Steven BURRILL, CEO of Burrill & Company (USA)

M. Ludo LAUWERS, Senior VP and Beerse Site Manager, Johnson&Johnson (BE)

M. Ashley STEVENS, President of the AUTM (USA)

M. Neil WEIR, Senior VP Global Research, UCB (BE)

The session will be introduced and moderated by John Hodgson (Senior Editor at Nature Biotechnology) and will be divided into three 30-minute talks dealing with the following subjects:

  • What is at stake with innovation today?
  • What are the trends of the 2011 market?
  •  What’s new with the Pharma / biotech / academia partnering integrating R&D?

 

Follow the example of these participants who already registred

Pharma
Abbott, Sanofi-Pasteur, MSD, Pfizer, Merck & Co, Merck Serono, Johnson & Johnson, DSM, TEVA, UCB, Les laboratoires Servier, Takeda, GlaxoSmithKline, Mérieux Development, Janssen Pharmaceuticals, Pierre Fabre, Laboratoires Fournier, LFB, Norgine, Mérieux Developpement...
Biotech
Ablynx, LFB, PXTherapeutic, Galapagos, Genfit, Debiopharm, Cytune Pharma, Genoscreen, Sigma-Aldrich, In cell Art, Plant Advanced Technologies, Algenics, BiolineRx, AbD Serotec, Novagraaf Technologies, Texcell, IdVectoR, Myosix, Delphi Genetics, Université de Liège Interface, Promethera Biosciences, Mellitech…
Academia
AUTM, Albert-Ludwigs-Universität Freiburg, Jagiellonian University, Geneva University, Leuven Catholic University, Academic medical center Amsterdam, Copenhagen University, Queen Mary Innovation Ltd, Pierre & Marie Curie University, Brussels University, Connectus, FIST, Netherlands Genomic Initiative, Boston University, Ghent University, Université Paris 11, Max Planck Innovation, Faculty of pharmacy of Lille, Université René Descartes - Faculty of Pharmacy, Conectus Alsace, Assistance Publique - Hôpitaux de Paris, Ifremer, Institut Curie, TTO Flanders, Cancer Research Technology Ltd, Max-Planck Innovation, Technion Technology Transfer, CEA, Royal Holloway University, University of Manitoba, etc.…
Service providers
Ascenion, IP Pragmatics, Licentia, Kurma Biofund, Burill &Company, 3M, KPMG, Vetter, Welience, Avenium consulting, Catalent Pharma, Bertin Pharma, FORENAP Pharma, AEPODIA, Bioceros, Sigma-Aldrich,…

Who will you meet? Click here to view the attending companies

 

Travel & Accommodation
Practical Information
Biofit 2010
26 & 27 October 2010 – Lille (Grand Palais)
Location
Conference Venue Lille Grand Palais
1, Boulevard des Citées-Unies, F-59777 Lille, France

Travelling to Lille
By air Lille Lesquin International Airport
Tel: +33 (0)3.20.49.68.68
www.lille.aeroport.fr

To have 30% off of your return ticket Air France, please ask us for the agreement.
http://w9.traveldoo.com/mice/connect.jsf?eid=10030AF

By train
Information concerning the SNCF (French railways): contact your travel agency or call 08 36 35 35 35 from France. TGV high speed trains (TGV Northern Europe, Thalys and Eurostar) stop at "Lille Europe" station, just 10 minutes walk from Lille Grand Palais. Other trains stop at "Lille Flandres" station, also 10 minutes walk from Lille Grand Palais.
Please contact us if you are interested in SNCF discount vouchers (only valid for train journeys within France).
www.sncf.fr

By car
• If you are coming from Paris (on the A1 motorway), Tournai, Mons, Brussels (on the A27 motorway), Valenciennes (on the A23 motorway): Leave the motorway by taking the 2nd exit, then follow the lane marked 2a which leads to Lille Grand Palais.

• If you are coming from Dunkerque, Bailleul, Calais, Boulogne (on the A25 motorway): Leave the motorway by taking the 1st exit – be careful, the exit is on your left – and then follow the lane marked 2a, which leads to Lille Grand Palais.

Find an hotel in Lille
> More information on biofit website : http://www.biofit-event.com/accommodation.html
> More information on Lille Tourist office : http://hebergement.lilletourism.com/liste-hotel-lille-3-etoiles.html

Consult accomodation & travel details by clicking here

 

Registration fees  
Two days of productive partnering and a cutting-edge conference program at moderate price!
   Mature companies 800 €*
  Emerging companies (less than 3 years) 450 €*
  Academia (Research institutes, universities,  tech-transfer offices) 150 €*
* Excluding VAT (19.6% VAT will be added as applicable)


Yassine CHIRZAD
T: +33 3 59 39 01 84
ychirzad@biofit-event.com
Aurélie VALENTIN
T: +33 1 40 09 68 72
avalentin@biofit-event.com

 

SUPPORTERS MEDIA SPONSOR
Assistance Publique – HOpitaux de Paris APBio   Big Pharma Market
ASEBIO - Spanish Association of Bioenterprise Adebag Biofutur
Adebiotech AlpsBiocluster Bio-IT World
Ascenion BIO Deutschland Biotech Actors
Biowin Club DEveloppeurs Innovaro Pharmalicensing 
EMBO Entreprise Europe Network Innovation & Industrie
European Biotechnology Network Europharm SMC La Gazette du Laboratoire
FlandersBio GENT BC Nature Events
GIS-IBISA Hungarian Biotechnology Association UniverCELLmarket 
IC Strategy Innoget  
International Association of Science Parks - IASP Licensing Executive Society  
Lithuanian Biotech Association One Nucleus  
Life Science Austria REseau Curie  
Oxfordshire Bioscience Network Shibuya  
REseau Trans-tech Technology Transfer office - University of Manitoba  
The TBN Group    

© IDIS 2010 | www.biofit-event.com